Company Filing History:
Years Active: 2006
Title: Hye-Rhan Jeong: Innovator in Poliovirus Vaccine Development
Introduction
Hye-Rhan Jeong is a notable inventor based in Daejeon Metropolitan, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines. His innovative work focuses on enhancing the safety and efficacy of poliovirus vaccines.
Latest Patents
Hye-Rhan Jeong holds a patent for an advanced oral poliovirus vaccine (Adv-OPV) that is designed to eliminate the risk of vaccine-associated paralytic poliomyelitis (VAPP). This invention involves a novel recombinant Sabin type 1 poliovirus vector that enhances the immunogenicity of neutralizing antibodies against polioviral infection. The patent includes a genomic nucleotide sequence of a parent Sabin type 1 poliovirus, a nucleotide sequence encoding an additional polioviral cleavage site, and a nucleotide sequence of a conformational epitope that encodes a VP1 neutralizing epitope of poliovirus types 2 or 3.
Career Highlights
Hye-Rhan Jeong is associated with Creagene Inc., where he continues to advance his research in vaccine development. His work has been pivotal in addressing public health concerns related to poliovirus infections.
Collaborations
He collaborates with esteemed colleagues, including Yong-Soo Bae and Sang-Gu Lee, who contribute to his research efforts and innovations in the field.
Conclusion
Hye-Rhan Jeong's contributions to vaccine development, particularly through his patented innovations, highlight his role as a key figure in the fight against poliovirus. His work not only enhances vaccine safety but also aims to improve public health outcomes globally.